Authors:
Schink, JC
Weller, E
Harris, LS
Cella, D
Gerstner, J
Falkson, C
Wadler, S
Citation: Jc. Schink et al., Outpatient taxol and carboplatin chemotherapy for suboptimally debulked epithelial carcinoma of the ovary results in improved quality of life: An Eastern Cooperative Oncology Group phase II study (E2E93), CANCER J, 7(2), 2001, pp. 155-164
Authors:
Westermann, AM
Grosen, EA
Katschinski, DM
Jager, D
Rietbroek, R
Schink, JC
Tiggelaar, CL
Jager, E
Vording, PZVS
Neuman, A
Knuth, A
Van Dijk, JDP
Wiedemann, GJ
Robins, HI
Citation: Am. Westermann et al., Pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer, EUR J CANC, 37(9), 2001, pp. 1111-1117
Authors:
Hartenbach, EM
Harris, LS
Bailey, HH
Grosen, EA
Larrison, E
Chen, D
Twiggs, LB
Schink, JC
Citation: Em. Hartenbach et al., Paclitaxel, carboplatin, and hexamethylmelamine (taxchex) as first-line therapy for ovarian cancer, CA J SCI AM, 5(6), 1999, pp. 348-355
Citation: Dg. Petereit et al., High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: Analysis of tumor recurrence - The University of Wisconsin experience, INT J RAD O, 45(5), 1999, pp. 1267-1274